News

Live Science on MSN13h
Ozempic-style drugs treat type 1 diabetes, not only type 2, study finds
A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...
Our Culture Mag on MSN20h
Midwest Strong, Science Backed: How Stem Cells Are Changing the Way We Heal
The Midwest has always been a region built on resilience. Whether you’re clocking in for a 10-hour shift at the plant, ...
The University of Manchester23h
New blood test could stop melanoma patients becoming resistant to treatment
The Christie NHS Foundation Trust together with the Cancer Research UK National Biomarker Centre and The University of Manchester has developed a new blood test that can tell doctors precisely how ...